Sandoz Group AG (SDZXF OTCQX) stock market data APIs
$43.9295
0(0%)
as of May 8, 2025
Sandoz Group AG Financial Data Overview
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
Prev. Close
43.9295
Open
43.9295
High
43.9295
Low
43.9295
52 wk Range
33.4471-48.858
Market Cap
18 656 M
P/E Ratio
0
Shares Outstanding
431 M
Revenue
10 384 M
EPS
0
Dividends (Yield)
0.0184
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sandoz Group AG data using free add-ons & libraries
Get Sandoz Group AG Fundamental Data
Sandoz Group AG Fundamental data includes:
- Net Revenue: 10 384 M
- EBITDA: 734 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-05-07
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sandoz Group AG News
New
Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
Sandoz Group Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Q1 2025 net sales of USD 2,480 million up by 3% in constant currencies (cc); stable in USD up by...
Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
Sandoz Group MEDIA RELEASE Agreement offers rights to commercialize proposed biosimilar of Yervoy®* for treatment of variety of cancer types, targeting net reference medicine sales of USD 2.5 billi...
Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
Earnings season is now in full swing, with a number of key companies due to report in the coming week, including four of the Magnificent 7 tech giants in focus. Uncertainty over US president Donald T...
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
Sandoz Group All proposals of Board of Directors approved Gilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for re-election confirmed Dividend of CHF 0...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
